01Clinical context
What is the finding?
Scar morphology, depth, tethering, skin type, pigment risk, active inflammation and previous treatment determine the assessment.
Acne Scars and Skin Texture · Medical Skin Care · Istanbul
Acne Scars and Skin Texture · Medical Skin Care · Istanbul
Acne Scars and Skin Texture
Active acne and established scarring are separate clinical questions; ice-pick, boxcar, rolling, hypertrophic and keloid scars do not share one target. A named care method, ingredient or infusion is not a diagnosis and does not establish personal suitability.
Online information cannot diagnose, select products or procedures, or promise an outcome. Final decisions require an in-person medical assessment.
Clinical Orientation
Finding · identity · evidence · safety
Four questions precede a personal plan.
The sequence prevents a category name from becoming an automatic treatment recommendation.
02Identity
What exactly is proposed?
Peels, medical microneedling, RF microneedling, fractional laser, subcision, injections and surgery act differently and are not equivalent.
03Evidence
What does the evidence support?
Evidence is morphology-, method- and endpoint-specific; returning scarred skin to ‘normal’ cannot be promised.
04Safety
When should it stop?
Pause and seek review for rapidly increasing inflammation, infection, delayed healing, marked pigment change or an enlarging raised scar.
Meaning and Boundary
Care is not a diagnosis
The category name does not determine the clinical decision.
Active acne and established scarring are separate clinical questions; ice-pick, boxcar, rolling, hypertrophic and keloid scars do not share one target.
What assessment may do
- Clarify a limited clinical aim
- Identify the exact method or product
- Compare risks and alternatives
- Set follow-up and stopping criteria
What must not be assumed
- Guarantee suitability or benefit
- Replace diagnosis or disease-directed treatment
- Create a public personal protocol
- Promise permanence, prevention or a general wellness effect
No single method erases every scar or guarantees normal skin texture.
Medical Suitability
Diagnosis and activity before care
Five checks come before selection.
History, examination, current treatment, contraindications and a proportionate alternative are reviewed together.
- 01
Clarify the problem
Scar morphology, depth, tethering, skin type, pigment risk, active inflammation and previous treatment determine the assessment.
- 02
Review current treatment
Medicines, allergies, previous procedures or infusions and relevant reactions are considered.
- 03
Identify the exact option
Peels, medical microneedling, RF microneedling, fractional laser, subcision, injections and surgery act differently and are not equivalent.
- 04
Compare alternatives
Control active acne, camouflage, observation, morphology-specific procedures or no intervention
- 05
Plan follow-up
Pause and seek review for rapidly increasing inflammation, infection, delayed healing, marked pigment change or an enlarging raised scar.
Care Path
Before · during · after
Safety depends on a complete, documented chain.
Peels, medical microneedling, RF microneedling, fractional laser, subcision, injections and surgery act differently and are not equivalent.
01Before
Confirm finding and skin state
Scar morphology, depth, tethering, skin type, pigment risk, active inflammation and previous treatment determine the assessment.
- Review history and examination
- Check contraindications
- Keep alternatives open
02During
Control exposure and response
Peels, medical microneedling, RF microneedling, fractional laser, subcision, injections and surgery act differently and are not equivalent.
- Maintain traceability
- Monitor tolerance
- Stop when safety changes
03After
Separate expected response from harm
Pause and seek review for rapidly increasing inflammation, infection, delayed healing, marked pigment change or an enlarging raised scar.
- Record observations
- Explain warning signs
- Provide a review route
No personal acid concentration, contact time, prescription medicine or home-treatment recipe is published.
Evidence and Limits
Method-, product- and indication-specific
Biology or popularity is not proof of clinical benefit.
Evidence is morphology-, method- and endpoint-specific; returning scarred skin to ‘normal’ cannot be promised.
Keep the indication exact
Evidence in one diagnosis or deficiency does not establish a general effect.
Keep the intervention exact
Peels, medical microneedling, RF microneedling, fractional laser, subcision, injections and surgery act differently and are not equivalent.
Keep endpoints separate
Symptoms, photographs, laboratory values and patient-reported outcomes are not interchangeable.
Retain uncertainty
No single method erases every scar or guarantees normal skin texture.
Manufacturer information may identify a product and instructions, but it is not treated as independent evidence of a general class effect.
Individual Plan
Reason · option · review · exit
Personalisation means tighter decisions, not unlimited combinations.
A plan remains limited to a defined question and can conclude that no procedure or infusion is appropriate.
Name the reason
Scar morphology, depth, tethering, skin type, pigment risk, active inflammation and previous treatment determine the assessment.
Name the option
Peels, medical microneedling, RF microneedling, fractional laser, subcision, injections and surgery act differently and are not equivalent.
Name the endpoint
Agree what would count as a meaningful and measurable change.
Name the exit
Pause and seek review for rapidly increasing inflammation, infection, delayed healing, marked pigment change or an enlarging raised scar.
Course and Follow-Up
Expected response · complication · reassessment
Repetition is never automatic.
Tolerance and the agreed clinical endpoint are reviewed separately before any further intervention.
- 01Before
Baseline
Record the starting clinical context and intended endpoint.
- 02Same day
Immediate review
Observe tolerance and unexpected reactions.
- 03Later
Clinical review
Compare the relevant finding without automatic attribution.
- 04Decision
Continue, change or stop
Pause and seek review for rapidly increasing inflammation, infection, delayed healing, marked pigment change or an enlarging raised scar.
Risks and Alternatives
Common, serious and delayed harm
Risk remains visible even when a treatment is described as supportive.
Inflammation, infection, persistent redness, pigment change, worsening scars and keloid activity may occur.
01Safety
Recognised harms
Inflammation, infection, persistent redness, pigment change, worsening scars and keloid activity may occur.
02Options
Alternatives
Control active acne, camouflage, observation, morphology-specific procedures or no intervention
03Action
Escalation
Pause and seek review for rapidly increasing inflammation, infection, delayed healing, marked pigment change or an enlarging raised scar.
04Decision
Withhold or stop
Treatment is withheld or stopped when the indication, consent, safety controls or follow-up cannot support a proportionate plan.
Treatment is withheld when diagnosis or rationale, product identity, consent, safety controls or follow-up is inadequate. Pause and seek review for rapidly increasing inflammation, infection, delayed healing, marked pigment change or an enlarging raised scar.
Istanbul and Follow-Up
Assessment and review must travel together
International care needs a workable safety route.
Travel does not shorten observation or remove the need for local medical access.
01Before travel
Organise the question
History and existing records prepare discussion without confirming treatment.
02In Istanbul
Assess in person
Scar morphology, depth, tethering, skin type, pigment risk, active inflammation and previous treatment determine the assessment.
03Treatment day
Keep exact records
Peels, medical microneedling, RF microneedling, fractional laser, subcision, injections and surgery act differently and are not equivalent.
04After return
Plan escalation
Pause and seek review for rapidly increasing inflammation, infection, delayed healing, marked pigment change or an enlarging raised scar.
The Doctor Aslan Approach
Clinical question before treatment label
Selection follows diagnosis, identity, evidence and safety.
Doctor Aslan keeps the clinical question, exact intervention, realistic limits, alternatives and follow-up in the same decision.
Assess first
Scar morphology, depth, tethering, skin type, pigment risk, active inflammation and previous treatment determine the assessment.
Verify identity
Peels, medical microneedling, RF microneedling, fractional laser, subcision, injections and surgery act differently and are not equivalent.
Limit the claim
No single method erases every scar or guarantees normal skin texture.
Accept no treatment
Observation or another established pathway may be the safer choice.
Medical responsibility: Dr İsmail AslanMedical review: 24 August 2026General patient information about Acne Scars and Skin Texture; no personal prescription or outcome guarantee
Frequently Asked Questions
Short and clear
Questions commonly asked before a decision.
These answers provide general orientation and do not replace personal diagnosis or treatment planning.
01What is Acne Scars and Skin Texture?+
Acne Scars and Skin Texture is described on this page as one defined clinical route. Its role, limits and possible alternatives are considered together rather than treating the method name as a personal recommendation.
02Who may be assessed for Acne Scars and Skin Texture?+
Suitability depends on the medical question, history, examination, the exact product or device where relevant, realistic aims and an individual benefit–risk assessment.
03What remains undecided after an online review?+
Diagnosis, definitive suitability, the treatment protocol, product, dose or device settings, expected response and the option not to proceed remain subject to personal medical assessment.
04How are treatment and follow-up in Istanbul planned?+
The in-person examination remains the decision point. Expected early reactions, warning signs, the direct contact route, return travel and access to appropriate local medical care are discussed before treatment.
Next Step
Define the question · verify the option · compare alternatives